Patch Clamp Combined with Voltage/Concentration Clamp to Determine the Kinetics and Voltage Dependency of N-Methyl-d-aspartate (NMDA) Receptor Open Channel Blockers
Electrophysiological techniques can be used to great effect to help determine the mechanism of action of a compound. However, many factors can compromise the resulting data and their analysis, such as the speed of solution exchange, expression of additional ion channel populations including other ligand-gated receptors and voltage-gated channels, compounds having multiple binding sites, and current desensitization and rundown. In this chapter, such problems and their solutions are discussed and illustrated using data from experiments involving the uncompetitive NMDA receptor antagonist memantine. Memantine differs from many other NMDA receptor channel blockers in that it is well tolerated and does not cause psychotomimetic effects at therapeutic doses. Various electrophysiological parameters of NMDA-induced current blockade by memantine have been proposed to be important in determining therapeutic tolerability; potency, onset and offset kinetics, and voltage dependency. These were all measured using whole cell patch clamp techniques using hippocampal neurons. Full results are shown here for memantine, and these are summarized and compared to those from similar experiments with other NMDA channel blockers. The interpretation of these results is discussed, as are theories concerning the tolerability of NMDA channel blockers, with the aim of illustrating how electrophysiological data can be used to form and support a physiological hypothesis.
Key wordsNMDA Uncompetitive Concentration dependence Concentration clamp Voltage dependence Kinetics
- 25.Rogawski MA, Yamaguchi SI, Jones SM et al (1991) Anticonvulsant Activity of the Low-Affinity Uncompetitive N-Methyl-D-Aspartate Antagonist (+/-)-5-Aminocarbonyl-10,11-dihydro-5H-dibenzo < a, d > cyclohepten-5, 10-imine (ADCI) - comparison with the Structural Analogs Dizocilpine (mK-801) and Carbamazepine. J Pharmacol Exp Ther 259:30–37PubMedGoogle Scholar